Display options
Cite
Schwartz NE, Albers GW. Is there a role for combinations of antiplatelet agents in stroke prevention?. Curr Treat Options Neurol. 2007;9(6):442-50doi: 10.1007/s11940-007-0045-y.
Schwartz, N. E., & Albers, G. W. (2007). Is there a role for combinations of antiplatelet agents in stroke prevention?. Current treatment options in neurology, 9(6), 442-50. https://doi.org/10.1007/s11940-007-0045-y
Schwartz, Neil E, and Albers, Gregory W. "Is there a role for combinations of antiplatelet agents in stroke prevention?." Current treatment options in neurology vol. 9,6 (2007): 442-50. doi: https://doi.org/10.1007/s11940-007-0045-y
Schwartz NE, Albers GW. Is there a role for combinations of antiplatelet agents in stroke prevention?. Curr Treat Options Neurol. 2007 Nov;9(6):442-50. doi: 10.1007/s11940-007-0045-y. PMID: 18173943.
Copy Download .nbib Format: NLM
Share it on

Curr Treat Options Neurol. 2007 Nov;9(6):442-50. doi: 10.1007/s11940-007-0045-y.

Is there a role for combinations of antiplatelet agents in stroke prevention?.

Current treatment options in neurology

Neil E Schwartz, Gregory W Albers

Affiliations

  1. Neil E. Schwartz, MD, PhD Stanford Stroke Center, Department of Neurology and Neurological Sciences, Stanford University, 701 Welch Road, #B325, Palo Alto, CA 94304, USA. [email protected].

PMID: 18173943 DOI: 10.1007/s11940-007-0045-y

Abstract

Antiplatelet medications are the agents of choice for secondary prevention of noncardioembolic ischemic strokes. Multiple clinical trials have proven their reliable albeit modest clinical benefits and relatively good safety profile. The most commonly recommended antiplatelet agents for secondary stroke prevention in North America and Europe are aspirin, clopidogrel, and the combination of aspirin and extended-release dipyridamole. Because of the multiple pharmacologic mechanisms available for platelet inhibition, combination antiplatelet agents have the potential for synergistic effects. However, combinations of antithrombotic agents do not necessarily improve clinical efficacy and are typically associated with increased toxicity. Clopidogrel and aspirin have been used in combination in patients with diverse arterial vascular diseases. Combination antiplatelet therapy with clopidogrel and aspirin has established clinical benefits, particularly in coronary disease and in patients who have undergone coronary stenting. Although it is tempting to extrapolate the benefits of clopidogrel and aspirin to the setting of secondary stroke prevention, recent clinical trials have failed to document significant clinical benefits in cerebrovascular patients. This failure has occurred because of a lack of significant efficacy for prevention of vascular events and a substantial increase in bleeding risk. Therefore, the clopidogrel and aspirin combination is not recommended for recurrent stroke prevention. In general, when clopidogrel is used for cerebrovascular patients, the addition of aspirin should be avoided unless there is a specific cardiac indication such as recent acute coronary syndrome or a coronary stent. The combination of aspirin and extended-release dipyridamole is supported by Class I data from two large studies demonstrating superiority over aspirin alone for recurrent stroke prevention. Although dual antiplatelet therapy with clopidogrel and aspirin has never been directly compared with the combination of aspirin and extended-release dipyridamole, clinical trial results favor the latter for secondary stroke prevention. Currently, there are no data for primary stroke prevention with dual antiplatelet agents regarding aspirin and extended-release dipyridamole. Limited data from the recent Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization Management and Avoidance (CHARISMA) trial indicate that the combination of clopidogrel and aspirin may be harmful, compared with aspirin alone.

References

  1. Neurology. 2001;57(5 Suppl 2):S20-3 - PubMed
  2. Lancet. 1996 Nov 16;348(9038):1329-39 - PubMed
  3. Circulation. 2006 Mar 14;113(10):e409-49 - PubMed
  4. Stroke. 2005 Jan;36(1):162-8 - PubMed
  5. Chest. 2004 Sep;126(3 Suppl):483S-512S - PubMed
  6. J Clin Invest. 1983 Nov;72(5):1521-5 - PubMed
  7. N Engl J Med. 1991 Oct 31;325(18):1261-6 - PubMed
  8. Arch Intern Med. 1999 Jun 14;159(11):1248-53 - PubMed
  9. Lancet. 1987 Dec 12;2(8572):1351-4 - PubMed
  10. Am J Med. 1996 Aug;101(2):199-209 - PubMed
  11. N Engl J Med. 2001 Aug 16;345(7):494-502 - PubMed
  12. Thromb Haemost. 2000 Nov;84(5):891-6 - PubMed
  13. Neurology. 2005 Apr 12;64(7):1117-21 - PubMed
  14. Lancet. 1989 Jun 3;1(8649):1215-20 - PubMed
  15. Semin Hematol. 1979 Jul;16(3):196-207 - PubMed
  16. Lancet. 2004 Jul 24-30;364(9431):331-7 - PubMed
  17. JAMA. 2002 Nov 20;288(19):2411-20 - PubMed
  18. Neurology. 2000 Mar 14;54(5):1022-8 - PubMed
  19. J Neurol Neurosurg Psychiatry. 1996 Feb;60(2):197-9 - PubMed
  20. N Engl J Med. 1987 May 14;316(20):1247-57 - PubMed
  21. Nat Clin Pract Cardiovasc Med. 2007 Mar;4(3):118-9 - PubMed
  22. Stroke. 1985 May-Jun;16(3):406-15 - PubMed
  23. Arch Neurol. 2005 Mar;62(3):403-8 - PubMed
  24. Lancet. 1999 Jun 26;353(9171):2179-84 - PubMed
  25. J Neurol Sci. 1996 Nov;143(1-2):1-13 - PubMed
  26. Lancet. 1991 Nov 30;338(8779):1345-9 - PubMed
  27. Stroke. 1983 Jan-Feb;14(1):5-14 - PubMed
  28. Ann Intern Med. 1998 Apr 1;128(7):541-4 - PubMed
  29. Stroke. 2005 Jun;36(6):1285-7 - PubMed
  30. Lancet. 1998 Jun 13;351(9118):1755-62 - PubMed
  31. Online J Curr Clin Trials. 1995 Mar 14;Doc No 174:[6442 words; 55 paragraphs] - PubMed
  32. J Clin Invest. 1975 Sep;56(3):624-32 - PubMed
  33. BMJ. 2002 Jan 12;324(7329):71-86 - PubMed
  34. Stroke. 2002 Apr;33(4):901-6 - PubMed
  35. N Engl J Med. 2006 Apr 20;354(16):1706-17 - PubMed
  36. Circulation. 2007 Mar 27;115(12):1615-21 - PubMed
  37. Lancet. 2006 Jun 10;367 (9526):1903-12 - PubMed
  38. Am J Ther. 2001 Nov-Dec;8(6):443-9 - PubMed
  39. Circulation. 2005 May 3;111(17 ):2233-40 - PubMed
  40. Postgrad Med. 2005 Jan;117(1):26-30 - PubMed
  41. JAMA. 2003 Jun 11;289(22):2947-57 - PubMed
  42. Stroke. 2001 Dec 1;32(12):2948-9 - PubMed
  43. N Engl J Med. 1989 Aug 24;321(8):501-7 - PubMed
  44. Neurology. 2005 Sep 27;65(6):835-42 - PubMed
  45. J Neurol Sci. 2004 Aug 30;223(2):179-84 - PubMed
  46. Arch Neurol. 1999 Sep;56(9):1087-92 - PubMed
  47. Lancet. 2006 May 20;367(9523):1665-73 - PubMed

Publication Types